D-Sight is a spin-off company from Vall d’Hebron Institute of Research (VHIR) lead by an experienced and committed team dedicated to the discovery and development of new innovative treatments for neurodegenerative diseases of the retina.
We are shaping the future of retinal diseases treatment with our first product in development: a first-in-class eye drop formulation for the prevention and treatment of diabetic retinopathy in its early stages.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Passeig De La Vall D'hebron, 119, Barcelona,catalonia 08035,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.dsight.es/
- Keywords
- Health-Circuit.
- HQ
- Barcelona, Catalonia
D-Sight S.l. Questions
D-Sight S.L.'s website is https://www.dsight.es/
D-Sight S.L.'s LinkedIn profile is https://es.linkedin.com/company/dsight-es
D-Sight S.L. has
2 employees.
View email and phone details for 2
employees at D-Sight S.L..
D-Sight S.L.'s industry is
Biotechnology Research
D-Sight S.L.'s top competitors are
Conus Airway,
Golden Gait Biotech,
Brainfocus,
Lumiris Spectral Solutions,
Aims-Medical Sl,
Health-Circuit,
Benviro,
Robopedics,
Atom H2,
Able Human Motion.
D-Sight S.L.'s categories are Biotechnology Research
D-Sight S.L.'s founding year is 2023
